Pregled bibliografske jedinice broj: 1282500
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review // Life, 13 (2023), 6; 1362, 20 doi:10.3390/life13061362 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1282500 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review
Autori
Confalonieri, Filippo ; Ferraro, Vanessa ; Di Maria, Alessandra ; Gaeta, Alessandro ; Vallejo-Garcia, Josè Luis ; Vinciguerra, Paolo ; Lumi, Xhevat ; Petrovski, Goran
Izvornik
Life (2075-1729) 13
(2023), 6;
1362, 20
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
vitreoretinal surgery ; surgical technique ; antiplatelet ; anticoagulant ; eye surgery
Sažetak
Background: Antiplatelets and anticoagulants have substantially influenced contemporary vitreoretinal surgical practices. The availability of new oral blood thinners has recently spurred a renewed interest in the clinical approach to vitreoretinal surgical conditions since it may be diffi- cult for the surgeon to collect sufficient evidence-based data to decide whether to discontinue or continue such medications. Materials and Methods: We conducted a systematic review on the use of antiplatelets and/or anticoagulants in the perioperative setting in vitreoretinal surgery and their possible complications, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The level of evidence, according to the Oxford Centre for Evidence-Based Medicine (OCEM) 2011 guidelines, and the quality of evidence, according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system, were assessed for all included articles. Results: In total, 2310 articles were initially extracted, out of which 1839 articles were obtained after duplicates were removed and their abstracts were screened. A total of 27 articles were included in the full-text review. Finally, a remaining 22 articles fulfilled the inclusion criteria. Conclusions: Even though there is just a small number of studies with solid results, the advantage of using antiplatelets and/or anticoagulants in vitreoretinal surgery seems to outweigh the disadvantages, which are mainly related to postoperative hemorrhagic complications.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus